709 related articles for article (PubMed ID: 17690121)
1. Clinical and operational value of the extensively drug-resistant tuberculosis definition.
Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC;
Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121
[TBL] [Abstract][Full Text] [Related]
2. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.
Migliori GB; Lange C; Centis R; Sotgiu G; Mütterlein R; Hoffmann H; Kliiman K; De Iaco G; Lauria FN; Richardson MD; Spanevello A; Cirillo DM;
Eur Respir J; 2008 Jun; 31(6):1155-9. PubMed ID: 18515555
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
4. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K
Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052
[TBL] [Abstract][Full Text] [Related]
5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
6. Extensively drug-resistant tuberculosis in california, 1993-2006.
Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
8. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
Prasad R
Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
[TBL] [Abstract][Full Text] [Related]
9. Problems of multidrug- and extensively drug-resistant TB.
Drug Ther Bull; 2012 Feb; 50(2):21-4. PubMed ID: 22329954
[TBL] [Abstract][Full Text] [Related]
10. New treatment options for multidrug-resistant tuberculosis.
Field SK; Fisher D; Jarand JM; Cowie RL
Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
[TBL] [Abstract][Full Text] [Related]
11. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
Chang KC; Yew WW
Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
[TBL] [Abstract][Full Text] [Related]
12. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
13. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.
Tang S; Zhang Q; Yu J; Liu Y; Sha W; Sun H; Fan L; Gu J; Hao X; Yao L; Xiao H
Scand J Infect Dis; 2011 Apr; 43(4):280-5. PubMed ID: 21247226
[TBL] [Abstract][Full Text] [Related]
14. Multidrug- and extensively drug-resistant tuberculosis, Germany.
Eker B; Ortmann J; Migliori GB; Sotgiu G; Muetterlein R; Centis R; Hoffmann H; Kirsten D; Schaberg T; Ruesch-Gerdes S; Lange C;
Emerg Infect Dis; 2008 Nov; 14(11):1700-6. PubMed ID: 18976552
[TBL] [Abstract][Full Text] [Related]
15. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
16. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
17. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.
Devaux I; Manissero D; Fernandez de la Hoz K; Kremer K; van Soolingen D;
Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338144
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.
Migliori GB; D'Arcy Richardson M; Sotgiu G; Lange C
Clin Chest Med; 2009 Dec; 30(4):637-65, vii. PubMed ID: 19925959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
